These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

898 related articles for article (PubMed ID: 32192494)

  • 1. Noncoding RNAs in gastric cancer: implications for drug resistance.
    Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
    Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
    Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
    Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
    Chen C; Tang X; Liu Y; Zhu J; Liu J
    Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of MiRNAs and LncRNAs on Multidrug Resistance of Gastric Cancer.
    Wu Y; Yang X; Xie Z; Hu H; Lei X; Niu D; Li S; Tuo L
    Comb Chem High Throughput Screen; 2022; 25(13):2127-2140. PubMed ID: 35366768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
    Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
    World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
    Lin Z; Lu S; Xie X; Yi X; Huang H
    Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The emerging role of noncoding RNAs in colorectal cancer chemoresistance.
    Wei L; Wang X; Lv L; Zheng Y; Zhang N; Yang M
    Cell Oncol (Dordr); 2019 Dec; 42(6):757-768. PubMed ID: 31359293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-Coding RNA as Biomarkers and Their Role in the Pathogenesis of Gastric Cancer-A Narrative Review.
    Bakinowska E; Kiełbowski K; Skórka P; Dach A; Olejnik-Wojciechowska J; Szwedkowicz A; Pawlik A
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulation of non-coding RNAs in gastric cancer.
    Yang Q; Zhang RW; Sui PC; He HT; Ding L
    World J Gastroenterol; 2015 Oct; 21(39):10956-81. PubMed ID: 26494954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Implications of MicroRNAs, Long Non-coding RNAs and Circular RNAs in Drug Resistance of Esophageal Cancer.
    Wei L; Sun J; Zhang N; Shen Y; Wang T; Li Z; Yang M
    Front Cell Dev Biol; 2021; 9():764313. PubMed ID: 34881242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of circular RNAs and long non‑coding RNAs in the clinical translation of gastric cancer (Review).
    Cao B; Liu G; Zhang W; Shi Y; Wei B
    Int J Mol Med; 2021 Jan; 47(1):77-91. PubMed ID: 33416088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNAs in anti-cancer drug resistance.
    Chen QN; Wei CC; Wang ZX; Sun M
    Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNAs in gastric cancer carcinogenesis and metastasis.
    Nasrollahzadeh-Khakiani M; Emadi-Baygi M; Schulz WA; Nikpour P
    Brief Funct Genomics; 2017 May; 16(3):129-145. PubMed ID: 27122631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noncoding RNAs in esophageal cancer: A glimpse into implications for therapy resistance.
    Yang Z; Ma R; Li J; Zhao L
    Pharmacol Res; 2023 Feb; 188():106678. PubMed ID: 36709789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer.
    Wei L; Sun J; Wang X; Huang Y; Huang L; Han L; Zheng Y; Xu Y; Zhang N; Yang M
    Front Cell Dev Biol; 2023; 11():1226639. PubMed ID: 37560164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Non-Coding RNAs in Drug Resistance of Gastric Cancer: Complex Mechanisms and Potential Clinical Applications.
    Meng X; Bai X; Ke A; Li K; Lei Y; Ding S; Dai D
    Biomolecules; 2024 May; 14(6):. PubMed ID: 38927012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
    Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
    J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-coding RNA in drug resistance of hepatocellular carcinoma.
    Ding B; Lou W; Xu L; Fan W
    Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non‑coding RNAs that regulate the Wnt/β‑catenin signaling pathway in gastric cancer: Good cop, bad cop? (Review).
    Shao Z; Gao D; Chen L; Ding W; Yu Q
    Oncol Rep; 2020 Oct; 44(4):1314-1321. PubMed ID: 32945460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
    Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
    Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.